Vision Risks With Weight-Loss Drugs Semaglutide and Topiramate Explored

A detailed comparison reveals potential vision issues linked to popular weight-loss medications.

Recent research highlights increased risks of vision complications, including optic neuropathy and glaucoma, associated with weight-loss drugs like semaglutide and topiramate, emphasizing the importance of patient-specific treatment choices.

Study Details:

Investigations into the ocular side effects of weight-loss medications have uncovered significant v…